Trial Profile
A prospective, observational study of witching weekly alendronate or risedronate to monthly minodronate in patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Nov 2016
Price :
$35
*
At a glance
- Drugs Minodronic acid (Primary) ; Alendronic acid; Risedronic acid
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics; Therapeutic Use
- 28 Nov 2016 New trial record